0001415889-18-001538.txt : 20181023
0001415889-18-001538.hdr.sgml : 20181023
20181023142844
ACCESSION NUMBER: 0001415889-18-001538
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181011
FILED AS OF DATE: 20181023
DATE AS OF CHANGE: 20181023
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ABELES JOHN H
CENTRAL INDEX KEY: 0000902418
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-00935
FILM NUMBER: 181133898
MAIL ADDRESS:
STREET 1: 2365 NW 41ST STREET
CITY: BOCA RATON
STATE: FL
ZIP: 33431
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Medite Cancer Diagnostics, Inc.
CENTRAL INDEX KEY: 0000075439
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 364296006
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 414 NORTH ORLEANS STREET
STREET 2: SUITE 502
CITY: CHICAGO
STATE: IL
ZIP: 60610
BUSINESS PHONE: 4078490290
MAIL ADDRESS:
STREET 1: 414 NORTH ORLEANS STREET
STREET 2: SUITE 502
CITY: CHICAGO
STATE: IL
ZIP: 60610
FORMER COMPANY:
FORMER CONFORMED NAME: CytoCore Inc
DATE OF NAME CHANGE: 20060815
FORMER COMPANY:
FORMER CONFORMED NAME: MOLECULAR DIAGNOSTICS INC
DATE OF NAME CHANGE: 20011009
FORMER COMPANY:
FORMER CONFORMED NAME: AMPERSAND MEDICAL CORP
DATE OF NAME CHANGE: 19990527
4
1
form4-10232018_111029.xml
X0306
4
2018-10-11
0000075439
Medite Cancer Diagnostics, Inc.
MDIT
0000902418
ABELES JOHN H
C/O MEDITE CANCER DIAGNOSTICS, INC.
10524 MOSS PARK RD. STE-204-357
ORLANDO
FL
32832
true
false
false
false
Common Stock
2018-08-13
4
J
0
40000
A
1300185
I
Northlea Partners, Ltd.
Common Stock
2018-10-11
4
P
0
266667
0.075
A
1566852
I
Northlea Partners, Ltd.
Common Stock
116350
D
40,000 shares were issued to Northlea Partners, Ltd. for accrued interest on a debt.
/s/ John H. Abeles, M.D.
2018-10-23